Cargando…
A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms
Antimicrobial peptides are evolving as novel therapeutic options against the increasing problem of multidrug-resistant microorganisms, and nisin is one such avenue. However, some bacteria possess a specific nisin resistance system (NSR), which cleaves the peptide reducing its bactericidal efficacy....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315181/ https://www.ncbi.nlm.nih.gov/pubmed/34105992 http://dx.doi.org/10.1128/AEM.00391-21 |
_version_ | 1783729679417475072 |
---|---|
author | Pérez-Ibarreche, Mariana Field, Des Ross, R. Paul Hill, Colin |
author_facet | Pérez-Ibarreche, Mariana Field, Des Ross, R. Paul Hill, Colin |
author_sort | Pérez-Ibarreche, Mariana |
collection | PubMed |
description | Antimicrobial peptides are evolving as novel therapeutic options against the increasing problem of multidrug-resistant microorganisms, and nisin is one such avenue. However, some bacteria possess a specific nisin resistance system (NSR), which cleaves the peptide reducing its bactericidal efficacy. NSR-based resistance was identified in strains of Streptococcus uberis, a ubiquitous pathogen that causes mastitis in dairy cattle. Previous studies have demonstrated that a nisin A derivative termed nisin PV, featuring S29P and I30V, exhibits enhanced resistance to proteolytic cleavage by NSR. Our objective was to investigate the ability of this nisin derivative to eradicate and inhibit biofilms of S. uberis DPC 5344 and S. uberis ATCC 700407 (nsr(+)) using crystal violet (biomass), 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) (viability) assays, and confocal microscopy (viability and architecture). When preestablished biofilms were assessed, both peptides reduced biofilm biomass by over 60% compared to that of the untreated controls. However, a 42% higher reduction in viability was observed following treatment with nisin PV compared to that of nisin A. Accordingly, confocal microscopy analysis revealed significantly more dead cells on the biofilm upper surface and a reduced thickness following treatment with nisin PV. When biofilm inhibition was assessed, nisin PV inhibited biofilm formation and decreased viability up to 56% and 85% more than nisin A, respectively. Confocal microscopy analysis revealed a lack of biofilm for S. uberis ATCC 700407 and only dead cells for S. uberis DPC 5344. These results suggest that nisin PV is a promising alternative to effectively reduce the biofilm formation of S. uberis strains carrying NSR. IMPORTANCE One of the four most prevalent species of bovine mastitis-causing pathogens is S. uberis. Its ability to form biofilms confers on the bacteria greater resistance to antibiotics, requiring higher doses to be more effective. In a bid to limit antibiotic resistance development, the need for alternative antimicrobials is paramount. Bacteriocins such as nisin represent one such alternative that could alleviate the impact of mastitis caused by S. uberis. However, many strains of S. uberis have been shown to possess nisin resistance determinants, such as the nisin resistance protein (NSR). In this study, we demonstrate the ability of nisin and a nisin derivative termed PV that is insensitive to NSR to prevent and remove biofilms of NSR-producing S. uberis strains. These findings will add new information to the antimicrobial bacteriocins and control of S. uberis research fields specifically in relation to biofilms and nsr(+) mastitis-associated strains. |
format | Online Article Text |
id | pubmed-8315181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83151812022-01-27 A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms Pérez-Ibarreche, Mariana Field, Des Ross, R. Paul Hill, Colin Appl Environ Microbiol Biotechnology Antimicrobial peptides are evolving as novel therapeutic options against the increasing problem of multidrug-resistant microorganisms, and nisin is one such avenue. However, some bacteria possess a specific nisin resistance system (NSR), which cleaves the peptide reducing its bactericidal efficacy. NSR-based resistance was identified in strains of Streptococcus uberis, a ubiquitous pathogen that causes mastitis in dairy cattle. Previous studies have demonstrated that a nisin A derivative termed nisin PV, featuring S29P and I30V, exhibits enhanced resistance to proteolytic cleavage by NSR. Our objective was to investigate the ability of this nisin derivative to eradicate and inhibit biofilms of S. uberis DPC 5344 and S. uberis ATCC 700407 (nsr(+)) using crystal violet (biomass), 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) (viability) assays, and confocal microscopy (viability and architecture). When preestablished biofilms were assessed, both peptides reduced biofilm biomass by over 60% compared to that of the untreated controls. However, a 42% higher reduction in viability was observed following treatment with nisin PV compared to that of nisin A. Accordingly, confocal microscopy analysis revealed significantly more dead cells on the biofilm upper surface and a reduced thickness following treatment with nisin PV. When biofilm inhibition was assessed, nisin PV inhibited biofilm formation and decreased viability up to 56% and 85% more than nisin A, respectively. Confocal microscopy analysis revealed a lack of biofilm for S. uberis ATCC 700407 and only dead cells for S. uberis DPC 5344. These results suggest that nisin PV is a promising alternative to effectively reduce the biofilm formation of S. uberis strains carrying NSR. IMPORTANCE One of the four most prevalent species of bovine mastitis-causing pathogens is S. uberis. Its ability to form biofilms confers on the bacteria greater resistance to antibiotics, requiring higher doses to be more effective. In a bid to limit antibiotic resistance development, the need for alternative antimicrobials is paramount. Bacteriocins such as nisin represent one such alternative that could alleviate the impact of mastitis caused by S. uberis. However, many strains of S. uberis have been shown to possess nisin resistance determinants, such as the nisin resistance protein (NSR). In this study, we demonstrate the ability of nisin and a nisin derivative termed PV that is insensitive to NSR to prevent and remove biofilms of NSR-producing S. uberis strains. These findings will add new information to the antimicrobial bacteriocins and control of S. uberis research fields specifically in relation to biofilms and nsr(+) mastitis-associated strains. American Society for Microbiology 2021-07-27 /pmc/articles/PMC8315181/ /pubmed/34105992 http://dx.doi.org/10.1128/AEM.00391-21 Text en Copyright © 2021 Pérez-Ibarreche et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Biotechnology Pérez-Ibarreche, Mariana Field, Des Ross, R. Paul Hill, Colin A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms |
title | A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms |
title_full | A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms |
title_fullStr | A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms |
title_full_unstemmed | A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms |
title_short | A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms |
title_sort | bioengineered nisin derivative to control streptococcus uberis biofilms |
topic | Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315181/ https://www.ncbi.nlm.nih.gov/pubmed/34105992 http://dx.doi.org/10.1128/AEM.00391-21 |
work_keys_str_mv | AT perezibarrechemariana abioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT fielddes abioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT rossrpaul abioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT hillcolin abioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT perezibarrechemariana bioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT fielddes bioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT rossrpaul bioengineerednisinderivativetocontrolstreptococcusuberisbiofilms AT hillcolin bioengineerednisinderivativetocontrolstreptococcusuberisbiofilms |